Corpus Intelligence EBITDA Bridge — DOMINION HOSPITAL 2026-04-27 02:41 UTC
EBITDA Bridge — DOMINION HOSPITAL
CCN 494023 | VA | 116 beds | Current EBITDA $9.4M → Pro Forma $11.8M (+$2.4M)
🛡️ Public data only — no PHI permitted on this instance.
EBITDA BRIDGE  ·  CCN 494023

DOMINION HOSPITAL
value-creation walk.

7-lever RCM bridge from current EBITDA to pro-forma — denial / underpay / DAR / coding / contract / cost discipline / cash acceleration. Each lever shows current vs benchmark target with data provenance.

$45.6M
Net Revenue HCRIS
$9.4M
Current EBITDA COMPUTED
+$2.4M
RCM EBITDA Uplift
$11.8M
Pro Forma EBITDA
+526bps
Margin Improvement
$1.7M
WC Released (1x)

Bridge Realization Estimate

ML model predicts what fraction of the bridge is achievable (accuracy: 60%, n=5,839)

72%
Realization (B)
$2.4M
Modeled Uplift
$1.7M
Risk-Adjusted
-$682K
Execution Discount
Occupancy RateHigher Occupancy Rate increases execution likeliho
Commercial Payer %Higher Commercial Payer % reduces execution likeli
Revenue per BedLower Revenue per Bed reduces execution likelihood
Payer DiversityHigher Payer Diversity increases execution likelih
Net-to-Gross RatioNet-to-Gross Ratio has minimal effect on execution

Expected realization: 72% of modeled bridge. Strengths: Occupancy Rate, Payer Diversity. Risks: Commercial Payer %, Revenue per Bed. Risk-adjusted uplift: $1.7M (vs $2.4M modeled).

EBITDA Bridge — 7 RCM Levers

Each bar shows the annual EBITDA impact at full run-rate. Revenue levers increase top-line; cost levers reduce operating expense; cash acceleration releases working capital. Calibrated to published research bands (Denial 12%→5% = $8-15M on $400M NPR).

Cost to Collect
Cost Savings | 12mo ramp
$912K
+200bp
Denial Rate Reduction
Revenue | 12mo ramp
$903K
+198bp
A/R Days Reduction
Cash Accel | 9mo ramp
$555K
+122bp
Clean Claim Rate
Cost Savings | 6mo ramp
$29K
+6bp
Total EBITDA Impact$2.4M

Lever Detail

Each value shows its data source. SELLER = seller data room, DEFAULT = model default, BENCHMARK = P75 peer benchmark.

LeverCurrentTargetRevenueCostEBITDAWCRamp
Cost to Collect4.5% DEFAULT2.5% BENCHMARK$0$912K$912K$012mo
Denial Rate Reduction12.0% DEFAULT6.5% BENCHMARK$878K$25K$903K$012mo
A/R Days Reduction52.00 DEFAULT38.00 BENCHMARK$140K$415K$555K$1.7M9mo
Clean Claim Rate88.0% DEFAULT96.0% BENCHMARK$0$29K$29K$06mo
Net Collection Rate93.5% DEFAULT33.1% BENCHMARK$0$0$0$018mo
CDI / Case Mix Index135.0% DEFAULT142.0% BENCHMARK$0$0$0$018mo

Implementation Timing Curve

Linear ramp to full run-rate per lever. Month 0 = close date. Partners should expect 60-70% of total uplift realized by month 12.

LeverM0M3M6M9M12M18M24M36
Cost to Collect$0$228K$456K$684K$912K$912K$912K$912K
Denial Rate Reduction$0$226K$452K$678K$903K$903K$903K$903K
A/R Days Reduction$0$185K$370K$555K$555K$555K$555K$555K
Clean Claim Rate$0$15K$29K$29K$29K$29K$29K$29K
Cumulative$0$654K$1.3M$1.9M$2.4M$2.4M$2.4M$2.4M

Returns Sensitivity (IRR / MOIC)

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Green = exceeds 20% IRR hurdle. Amber = 15-20%. Red = below hurdle or loss. RCM uplift of $2.4M is added at exit.

Entry \ Exit9.0x10.0x11.0x11.5x12.0x
8.0x48% / 7.1x52% / 8.2x57% / 9.4x58% / 10.0x60% / 10.5x
9.0x43% / 5.9x47% / 7.0x52% / 8.0x53% / 8.5x55% / 9.0x
10.0x38% / 5.0x43% / 5.9x47% / 6.9x49% / 7.3x51% / 7.8x
11.0x34% / 4.3x39% / 5.1x43% / 5.9x45% / 6.4x47% / 6.8x
12.0x30% / 3.6x35% / 4.4x39% / 5.2x41% / 5.6x43% / 5.9x

Covenant Headroom (at 10x Entry, 6.5x Max Leverage)

8.5x
Entry Leverage
6.7x
Pro Forma Leverage
-0.2x
Headroom (turns)
-4%
EBITDA Cushion

Pro forma EBITDA can decline -4% before the 6.5x covenant trips. RCM uplift reduces leverage from 8.5x to 6.7x, adding 1.7 turns of cushion.

5-Year Value Creation Waterfall

EBITDA trajectory: 3% organic growth + RCM uplift ramp (full run-rate at month 18).

Base EBITDARCM UpliftTotalMargin
Entry$9.4M$9.4M20.6%
Year 1$9.7M+$1.6M$11.3M24.8%
Year 2$10.0M+$2.4M$12.4M27.2%
Year 3$10.3M+$2.4M$12.7M27.8%
Year 4$10.6M+$2.4M$13.0M28.5%
Year 5$10.9M+$2.4M$13.3M29.2%
$94.1M
Entry EV (10x)
$146.5M
Exit EV (11x)
$52.3M
Value Created
$13.3M
Exit EBITDA
$15.0M
Organic Growth
$24.0M
RCM Value Creation
$13.3M
Multiple Expansion

Achievement Sensitivity

What if we only achieve a fraction of each lever? 50% = conservative, 75% = base management case, 100% = plan, 120% = stretch.

Lever50%75%100%120%
Cost to Collect$456K$684K$912K$1.1M
Denial Rate Reductio$452K$678K$903K$1.1M
A/R Days Reduction$278K$416K$555K$666K
Clean Claim Rate$15K$22K$29K$35K
Total$1.2M$1.8M$2.4M$2.9M

Peer Context — Where This Hospital Sits

Key metrics vs 52 size-matched peers. Low percentile on margin/efficiency metrics = more room for improvement = larger bridge opportunity.

MetricHospitalP25P50P75Percentile
Op Margin20.6%-6.7%6.0%15.7%
P88
Net-to-Gross26.4%20.4%26.5%33.1%
P48
Occupancy78.5%46.7%64.8%78.3%
P75
Rev/Bed$393K$420K$1.4M$1.9M
P21
Exp/Bed$312K$460K$1.3M$1.8M
P10

Bridge Methodology

Coefficients calibrated to published research bands: denial 12%→5% = $8-15M on $400M NPR. Current metrics estimated from HCRIS public data and ML predictions. Target metrics set at P75 peer benchmarks with 60% gap closure assumption. Revenue levers use NPR × delta × avoidable share. Cost levers use claims volume × cost per reworked claim. Working capital from AR reduction is one-time cash (not included in recurring EBITDA). Returns assume 5.5x leverage, 3% organic growth, 10%/yr debt paydown.

Data: HCRIS FY2022 | 6,123 hospitalsSources: HCRISML